Pacific Biosciences of California Inc (PACB) is down Thursday morning, with the stock losing -1.08% in pre-market trading to 3.68. PACB's short-term technical score of 25 indicates that the stock has traded less bullishly over the last month than 75% of stocks on the market. In the Medical Devices industry, which ranks 118 out of 146 industries, PACB ranks higher than 37% of stocks. Pacific Biosciences of California Inc has fallen 28.87% over the past month, closing at $5.53 on February 29. During this period of time, the stock fell as low as $3.52 and as high as $6.09. PACB has an average analyst recommendation of Strong Buy. The company has an average price target of $11.46.
PACB has an Overall Score of 40. Find out what this means to you and get the rest of the rankings on PACB!